INTRODUCTION
============

In Korea, the prevalence of diabetes and its complications is rapidly increasing, thereby leading to a significant rise in health care expenditures \[[@B1]\]. It is well known that cardiovascular disease is the most common cause of death in type 2 diabetes patients. Moreover, about 79% of patients with diabetes die of cardiac complications after a myocardial infarction \[[@B2],[@B3]\]. Cardiovascular disease (30.6%) is the most common cause of mortality in patients with type 2 diabetes in Korea \[[@B1]\]. The cost of treating coronary artery disease (CAD) is reported to be US \$14,680 per patient, and holds the rank of second highest in economic burden for diabetic complications \[[@B4]\].

Compared to the nondiabetic population, diabetic patients have distinguished characteristics of CAD: higher prevalence \[[@B5]\], more extensive, diffuse, calcified coronary lesions, increased rates of left ventricular dysfunction, and silent ischemia \[[@B6]\]. Although invasive coronary angiography (ICA) is known as the \'gold standard\' for detection of CAD, it is not applicable in every CAD candidate due to its several limitations such as expense, invasive nature and complications. So several noninvasive diagnostic tools were suggested for substituting ICA; however, which tool should replace invasive angiography still remains controversial.

A 64-slice multidetector computed tomography (MDCT) is the current technique of choice for noninvasive angiography because it is simple, fast, and reproducible \[[@B6]\]. Several observational studies \[[@B7],[@B8]\] in the general population have shown that MDCT is a safe and feasible modality for evaluating acute chest pain. Moreover, in low-risk chest pain patients, MDCT is at least as good as a nuclear stress imaging study \[[@B9]\]. However, few studies have reported the diagnostic accuracy of MDCT in patients with diabetes compared to the nondiabetic population, especially among Asians such as Koreans who have distinctive features different from western patients \[[@B10]\]. The aim of this study is to evaluate the usefulness of MDCT coronary angiography by comparing it with conventional coronary angiography in Korean patients with type 2 diabetes.

METHODS
=======

Study population
----------------

From September 2007 to May 2008, MDCT was performed within 30 days of catheterization in 240 patients (147 male) at Yeungnam University Hospital who were scheduled to have conventional coronary angiography for evaluation of chest pain. Seventy-four patients had type 2 diabetes (40 male), and the other 166 were nondiabetes as the control group (107 male). Criteria for the diagnosis of diabetes, recommended by the American Diabetes Association \[[@B11]\], are as follows: 1) symptoms of diabetes plus spontaneous plasma glucose concentration ≥200 mg/dL (11.1 mmol/L), or 2) fasting plasma glucose level ≥126 mg/dL (7.0 mmol/L). The control group was defined as nondiabetic patients who have taken previously oral hypoglycemic agents or insulin injection, or individuals that did not meet the diagnostic criteria for diabetes. There were 15 patients (8 type 2 diabetes) who had coronary stents placed previously. Exclusion criteria consisted of atrial fibrillation, renal insufficiency (serum creatinine ≥120 mmol/L), iodine contrast allergy, severe claustrophobia, and pregnancy. All patients provided informed consent, and the study protocol was approved by our local ethics committee, as well as the Institutional Review Board of Yeungnam University Hospital.

CT protocols
------------

The following scanning parameters were used for 64-slice MDCT (DVCT; GE Healthcare, Milwaukee, WI, USA): electrocardiogram-triggered X-ray tube modulation, 64-channel detectors along the z-axis, a tube voltage of 120 kV, a tube current of 350 to 650 mA (depending on patient size), a scan field view of 25 cm, a gantry rotation of 0.35 seconds per rotation, a matrix of 512×512, a slice width of 0.625 mm, and a helical pitch of 0.16. A single oral dose of 25 to 50 mg metoprolol tartrate (Betaloc®; Yuhan Corp., Seoul, Korea) was administrated 1 hour before CT angiography (CTA) if the patient\'s heart rate was \>65 beats per minute. Prior to scanning, patients fasted, were placed in a supine position, and received 1.25 to 2.5 mg of sublingual isosorbid dinitrate so long as they were asymptomatic (Isoket®, Spray; Schwarz Pharma, Munchenstein, Switzerland). After 2 localization scans, a low-dose native scan of the heart was performed for coronary calcium detection and scoring. A bolus of 80 mL of iodixanol (Visisense®, 320 mgI/mL; Taejoon Pharma., Seoul, Korea) was injected into an antecubital vein via an 18-gauge catheter at a flow rate of 4 mL/sec followed by 50 mL saline solution. Bolus tracking was performed with a region of interest placed into the ascending aorta.

Coronary artery calcium scoring
-------------------------------

Coronary artery calcium scoring was performed using gated noncontrast images acquired prior to CTA. Images were analyzed using GE Advantage Workstation 4.4 (Advantage Workstation 4.4; GE Healthcare, Milwaukee, WI, USA) with Smartscore software. Using the Agatston method, calcium detection and quantification was performed by an electrocardiographically triggered, sequential step-and-shoot acquisition mode, with 120 kV tube voltage, 430 mA tube current, and 2.5 mm slice thickness.

MDCT data analysis
------------------

Stenosis evaluation was done using a modified American College of Cardiology/American Heart Association(ACC/AHA) segmentation model \[[@B12]\]. All CTA images were evaluated on a 3D image analysis workstation (Advantage Workstation 4.4). Images were analyzed by 2 experienced observers blinded to the catheterization results. First, each segment was evaluated for whether it was interpretable or not. We defined significant CAD as vessels with ≥50% reduction in lumen diameter. In the case of multiple lesions in a given segment, the segment was classified according to the worst segment.

ICA
---

ICA was performed using standard techniques. Vascular access was obtained using a femoral approach with the Seldinger technique. Coronary angiograms were visually evaluated by 2 experienced observers blinded to the MDCT data. Similar to MDCT, a significant lesion was defined as a ≥50% luminal narrowing.

Statistical analysis
--------------------

To evaluate the diagnostic accuracy of MDCT, we defined \"positive\" if there was the discrepancy between MDCT and ICA for results from the same segment. If either observer between two tests was not able to assess the segment, the case was also deemed \"positive\" for a discrepancy. Sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV) for MDCT were calculated based on ICA as the \"gold standard.\" Statistical analysis was done using SPSS version 13.0 for windows (SPSS Inc., Chicago, IL, USA). Results were expressed as a mean value±standard deviation for continuous variables. Qualitative data are presented in numbers (%). To determine the significant differences between MDCT and ICA, a McNemar test was used and a *P* value of less than 0.05 was considered to be statistically significant. Agreement for significant stenosis was expressed by a kappa index(*k*). A *k* value of 0 represents poor agreement, 0.01 to 0.20 represents slight agreement, 0.21 to 0.40 is fair agreement, 0.41 to 0.60 moderate agreement, 0.61 to 0.80 good agreement, and \>0.8 excellent agreement.

RESULTS
=======

Patient characteristics
-----------------------

Patient characteristics are summarized in [Table 1](#T1){ref-type="table"}. Patients with type 2 diabetes had a significantly higher coronary calcium score (type 2 diabetes vs. control: mean 658.6 vs. 426.4 Agatston score), creatinine (114.9±88.4 µmol/L vs. 88.4±17.7 µmol/L), a lower total bilirubin (11.3±4.5 µmol/L vs. 12.0±5.0 µmol/L), and direct bilirubin (3.4±1.6 µmol/L vs. 4.5±1.7 µmol/L) (*P*\<0.05). Lipid profiles and C-reactive protein were not different from the control group. There was also no significant difference in body mass index (BMI) between both groups. Final clinical diagnoses of patients are shown in [Fig. 1](#F1){ref-type="fig"} with chronic stable angina pectoris as the most common diagnosis for both diabetics (48.6%) and the control group (52.4%).

Quality of MDCT image analysis
------------------------------

We classified image quality into three categories: good, adequate and poor. The good quality (219, 91.3%) was defined as a clear image with no difficulties reading. Adequate quality (7, 2.9%) was defined as an interpretable image despite some interruption, whereas poor quality (14, 5.8%) included images have artifacts hard to interpret accurately. We identified several reasons for poor image quality including: multiple factors being the largest contributor (6, 42.9%), followed by irregular heart rhythm (4, 28.6%), calcified atherosclerosis (3, 21.4%), and respiratory artifact (1, 7.1%).

Diagnostic accuracy of 64-slice MDCT between nondiabetes and diabetes
---------------------------------------------------------------------

MDCT results are summarized in [Table 2](#T2){ref-type="table"}. Of the 4,064 coronary artery segments, 4,062 segments were candidates for both MDCT and ICA analysis, and 706 segments were detected to be significant ICA lesions in all patients. In patients with type 2 diabetes, there were 226 significant stenotic portions of 1,109 segments in ICA. On a per-segment basis, MDCT had a sensitivity of 89.4% in detecting significant lesions in ICA, and a specificity of 96.4% ([Table 3](#T3){ref-type="table"}). The PPV was 85.8%, NPV was 97.4%, and accuracy was 95.0%. In the control group, sensitivity, specificity, PPV, and NPV were 83.8%, 97.6%, 88.0%, and 96.6%, respectively.

On a per-vessel basis, sensitivity, specificity, PPV, and NPV for MDCT were 95.1%, 92.9%, 94.4%, and 93.8%, respectively in patients with diabetes. The nondiabetes group showed high sensitivity, specificity, PPV, and NPV with 95.2%, 96.4%, 96.4%, and 95.2%, respectively. Accuracy of both diabetes and nondiabetes group were 94.1% and 95.8%. On a per-patient basis of diabetes, MDCT correctly detected significant CAD in 63 of 64 cases for an overall sensitivity of 98.4%. MDCT had a specificity, PPV, and NPV of 100%, 98.4%, and 90%, respectively. Accurate determination of the presence or absence of significant CAD was made in 72 of 74 (97.3%) in patients with diabetes, and the accuracy of the control group was 98.8%. Through a McNemar test, all segment, vessel, and patient based analyses showed no significant differences between MDCT and ICA regardless of being diabetic or not.

Influence of coronary calcium score (CCS) on MDCT accuracy
----------------------------------------------------------

We evaluated the accuracy of MDCT in detecting significant CAD according to CCS. In the type 2 diabetes group, the sensitivity, specificity, PPV, and NPV were not influenced by the degree of calcium score ([Table 4](#T4){ref-type="table"}). The sensitivity, specificity, PPV, and NPV remained 100% when calcium scores were moderate (100≤CCS\<400) or high (CCS≥400). Also, there were no differences between MDCT and ICA irrespective of diabetes.

Influence of BMI on MDCT accuracy
---------------------------------

We examined the accuracy of MDCT in detecting significant stenosis in a given patient using BMI ([Table 5](#T5){ref-type="table"}). According to the definition of obesity (BMI ≥25 kg/m^2^) for Koreans \[[@B13]\], we classified patients into two groups: normal/overweight (nonobese) vs. obese. Although NPV of the diabetic group slightly dropped to 85.7%, sensitivity, specificity and PPV remained at 97.2%, 100%, and 100%, respectively in patients with a BMI \<25 kg/m^2^. MDCT remained highly accurate in the presence of obesity, with a sensitivity, specificity, PPV, and NPV of 100% for all patients. There were no significant differences between MDCT and ICA with or without diabetes.

DISCUSSION
==========

As the prevalence of diabetes continues to rise rapidly in Korea, diabetes and its many complications have become a major contributor to increased morbidity and mortality. According to Kim et al. \[[@B1]\], diabetes is the fifth-leading cause of death in Korea, with a two-fold increased death rate among diabetics compared to nondiabetics; moreover, diabetes-related mortality was found to be 19.6 per 100,000 persons in 2009. It is well known that cardiovascular disease is the most common cause of death (30.6%); therefore, the need for appropriate diagnosis and cost-effective management of CAD has become a rising concern. Although the gold standard for CAD detection is known to be coronary angiography, there are several limitations to this procedure: 1) invasiveness, 2) expense, 3) small but definite risk of complications, and 4) the need for a skillful operator and special facilities. Given these limitations, multiple noninvasive methods have been developed and are now available. These can be divided into functional and anatomical imaging. Functional imaging examines the hemodynamic changes, whereas anatomical imaging permits direct visualization of the coronary arteries \[[@B6]\]. There are widely used functional imaging techniques to detect CAD such as positron emission tomography or single photon emission computed tomography and myocardial contrast or stress echocardiography \[[@B6]\]. These tests are useful in defining ischemic territories and predicting myocardium reversibility, but they have several limitations: That methods have some risks because of using pharmacologic stress inducing perfusion defects manner. Moreover, they do not permit direct visualization of the coronary arteries. Specificity of such tests tends to be lower, thereby occasionally requiring other tests for further evaluation.

A 64-slice MDCT is a newer, more widely available method to assess coronary artery disease more directly irrespective of symptoms \[[@B9]\]. Previous studies in the general population reported MDCT sensitivity and specificity as 95% to 99% (95% credible interval \[Crl\]) and 83% to 94% (95% Crl), respectively \[[@B14]\]. Miller et al. \[[@B15]\] provided a diagnostic performance of a 64-slice MDCT with 291 symptomatic patients (23% of whom have diabetes), and its sensitivity, specificity, PPV, and NPV were 85%, 90%, 91%, and 83%, respectively in a patient-based analysis. They concluded that although MDCT cannot be used as a replacement for ICA, it may help guide clinician decisions as to whether a patient needs further invasive studies \[[@B16]\]. In our study, 64-slice MDCT demonstrated high quality noninvasive coronary angiograms that accurately detected significant lesions of symptomatic patients with type 2 diabetes. Only a few studies on 64-slice MDCT performance in diabetic patients have been done; one of them by Schuijf et al. \[[@B17]\] reported that MDCT is a feasible noninvasive test in type 2 diabetes patients with both a 95% sensitivity and specificity of interpretable segments (220/256, 86%). When uninterpretable segments were included, sensitivity and specificity dropped to 81% and 82%, respectively. The present study shows relatively higher quality image (93.4% above adequate image), with 98.4% sensitivity and 100% specificity for diabetic patients regardless of imaging quality. This is consistent with meta-analyses results, which showed that the sensitivity of a 64-slice CT (98%) was significantly higher than that of a 16-slice CT (95%) in a patient-based analysis \[[@B18]\]. Because a 64-slice MDCT has increased slices per gantry rotation (64 vs. 16) and a faster gantry speed (330 vs. 375 ms/rotation), the quality of image is increased; therefore, we were able to identify more accurate images compared with former studies. At the bedside, these results may have important clinical implications. Patients with diabetes can be delay proper diagnosis and management because they present atypical chest pain often confused with gastrointestinal or pulmonary symptoms, so high specificity and NPV of MDCT could be useful in reducing unnecessary invasive studies. MDCT could be also beneficial in the preoperative assessment of a noncardiac surgery, rapid triage in an emergency center or outpatient department, and evaluation of equivocal stress test results. Therefore, the risks and costs of invasive coronary angiogram could be avoided in a substantial number of diabetic patients by ruling out significant CAD with MDCT.

It is well known that patients with type 2 diabetes experience more diffuse, calcified, and extensive CAD, with significantly higher coronary calcium scores compared to controls. Calcified atherosclerosis has been identified as the main reason for poor image quality (46%, included multiple factors). However, there were no significant differences between sensitivity and specificity in both groups, probably due to small voxel size effect. Calcium deposits form a metal density that overwhelms the density of other tissues (calcium blooming effect), leading to misinterpreted adjacent plaques through artifacts attenuating low-energy X-rays (beam-hardening artifacts). Because small voxel size reduces and modifies these artifacts \[[@B19]\], 64-slice MDCT ameliorates imaging challenges and is helpful in detecting CAD regardless of high coronary calcium scores in diabetic groups.

Raff et al. \[[@B19]\] pointed out that factors related to poor image quality included not only calcium scores over 400, but also obesity (BMI ≥30 kg/m^2^) and heart rates over 70 beats/min. In a recent study, Dewey et al. \[[@B20]\] also reported that increased BMI, heart rate, and the presence of breathing artifact were associated with worse image quality.

Our study found that the aforementioned factors are not associated with imaging quality and diagnostic accuracy. Because BMI is a distinctive characteristic in this study compared with Caucasian-based research, we suggest that MDCT may be favorable in far-east Asians including Koreans. Asia-Oceanian use different BMI cutoffs for overweight (23 kg/m^2^) and obese (25 kg/m^2^) patients compared to Western measures of BMI and commonly tend to have a more lean body shape than Caucasians \[[@B13]\]. Koreans generally have a higher total body fat content and higher abdominal fat distribution than Caucasians. It is well known that they develop obesity-related complications at a lower BMI level \[[@B21]\]. This point implies that previous surveys about the applicability of MDCT for Caucasians cannot be applied to all ethnicities. In fact, because obesity is common in Western patients with diabetes, adequate adjustments such as scanner settings of kV and mA must be considered \[[@B20]\]. Therefore, we believe that the ethnic differences in obesity, for example, are the reason for different image quality and accuracy. Dewey et al. \[[@B20]\] showed that Asians have a tendency for better imaging quality compared to Caucasians (odds ratio, 2.68; *P*=0.06) and significantly better quality than African Americans. Therefore, Koreans may be in a more favorable group with lesser variables affected by body size in comparison to Caucasians.

It is widely accepted that the accuracy of distal segments is lower than that of proximal segments because less blood flow due to small diameters reduces contrast-to-noise, making it difficult to interpret peripheral lesions \[[@B22]-[@B26]\]. This study was consistent with prior results. The sensitivity of 2nd diagnostic and posterior descending artery (PDA) branches dropped sharply to 25% and 33.3%, respectively. Namgung et al. \[[@B27]\] had reported conflicting results with higher sensitivity in distal segments (95%) compared to proximal segments (89%), as well as a greater degree of calcification and motion artifact at the proximal segment. According to Yun et al. \[[@B28]\], diameters of the distal segment of left anterior descending artery and PDA of right coronary artery were 2.16±0.39 mm (median, 2.09 mm) and 2.09±0.48 mm (median, 2.02 mm), respectively for Koreans. Although it is believed that coronary plaques are more prevalent in the proximal segments of each vessel regardless of diabetes \[[@B29]\], diabetic patients often present with equivocal symptoms that could lead to physician misdiagnosis. Additionally, this raises the concern that perhaps radiologists should be more thorough in interpreting peripheral lesions and selecting patients for further study.

Our study has several limitations. Given this is a cross-sectional, single-center study, the diagnostic accuracy of MDCT may not represent the true accuracy in all Koreans with diabetes. Since including all patients had chest pain possible to influence the results, thus selection bias may be not excluded in this study. Limitations of coronary 64-slice MDCT include radiation-exposure \[[@B30]\], the use of contrast, the need for heart rate control, and anatomical imaging not directly indicative of ischemic changes.

In conclusion, our results demonstrate that there is no significant difference in accuracy between invasive coronary angiogram and MDCT regardless of diabetes. Thus, MDCT may be helpful in reducing unnecessary invasive studies for diabetic patients with chest pain, and may facilitate more reliable decisions for physicians in Korea.
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![We clinically classified patients with chest pain as having myocardial infarction, angina pectoris, or other according to changes in cardiac enzymes and electrocardiogram. Clinically, we classified unstable angina pectoris in patients as chest pain aggravated by exercise/exertion; otherwise, it was considered chronic stable angina pectoris. Variant angina pectoris and myocardial bridging were diagnosed based on characteristic findings on invasive coronary angiography. T2DM, type 2 diabetes; STEMI, ST elevation myocardiac infarction; NSTEMI, non-ST elevation myocardiac infarction; USAP, unstable angina pectoris; CSAP, chronic stable angina pectoris; VAP, variant angina pectoris.](dmj-37-54-g001){#F1}

###### 

Baseline clinical characteristics of subjects

![](dmj-37-54-i001)

Values are presented as mean±standard deviation or number (%).

T2DM, type 2 diabetes; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; CCS, coronary calcium score; Hb, hemoglobin; ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transpeptidase; ALP, alkaline phosphatase; T-bil, total bilirubin; D-bil, direct bilirubin; BUN, blood urea nitrogen; Cr, creatinine; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.

^a^*P*\<0.05.

###### 

Diagnostic accuracy of 64-slice MDCT to ICA in all patients
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MDCT, multidetector computed tomography; ICA, invasive coronary angiography; PPV, positive predictive value; NPV, negative predictive value; NS, not significant; LAD, left anterior descending artery; LCX, left circumflex artery; OM, obtuse marginal branch; RCA, right coronary artery; PDA, posterior descending artery; PL, postero-lateral branch.

###### 

Comparison of diagnostic accuracy between nondiabetes and diabetes

![](dmj-37-54-i003)

PPV, positive predictive value; NPV, negative predictive value; T2DM, type 2 diabetes; NS, not significant.

###### 

The effect of coronary calcium score on diagnostic accuracy of 64-slice MDCT
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MDCT, multidetector computed tomography; PPV, positive predictive value; NPV, negative predictive value; CCS, coronary calcium score; NS, not significant; T2DM, type 2 diabetes.

###### 

The effect of obesity on diagnostic accuracy of 64-slice MDCT
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MDCT, multidetector computed tomography; PPV, positive predictive value; NPV, negative predictive value; BMI, body mass index; NS, not significant; T2DM, type 2 diabetes.
